In a blow to its obesity pipeline, Pfizer drops danuglipron after liver injury case

Pfizer has discontinued its once-daily obesity pill danuglipron after a patient in one of its clinical trials had a liver injury that may have been drug-induced. A Pfizer spokesperson told Endpoints News that the case ...

Apr 14, 2025 - 11:46
 0
In a blow to its obesity pipeline, Pfizer drops danuglipron after liver injury case
Pfizer has discontinued its once-daily obesity pill danuglipron after a patient in one of its clinical trials had a liver injury that may have been drug-induced. A Pfizer spokesperson told Endpoints News that the case ...